Acura Pharmaceuticals, Inc. · Palatine, IL United States · (NASDAQ (CM): ACUR)
Company Description
More Companies in: Palatine, Illinois
More Companies in These Related Industries: Pharmaceutical Preparation Mfg
View Acura Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
Acura Pharmaceuticals is working to make it harder to abuse otherwise good drugs. The company has developed a technology to add abuse-deterring agents to commonly abused pharmaceuticals. If a drug with these agents (what Acura calls Aversion Technology) is taken in excess, the ingredients cause unpleasant symptoms shortly after ingestion. If a tablet is crushed and inhaled other ingredients will cause nasal irritation; and if an abuser attempts to dissolve the powder, it will form a non-injectable gel. Lead product candidate Acurox combines Aversion Technology with the commonly abused opioid painkiller oxycodone HCl. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Acura Pharmaceuticals, Inc. Reports
Key Acura Pharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (CM): ACUR Headquarters |
| Fiscal Year-End | December |
| 2009 Employees | 15 |
Acura Pharmaceuticals, Inc. Executives
16 executives listed for Acura Pharmaceuticals, Inc.'s Palatine, IL location.
| Title | Name & Bio | Contact |
| Chairman | Richard Markham | |
| President, CEO, and Director | Andrew Reddick | |
| SVP and COO | Robert Jones |
Competition
Top Acura Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
